Sugi Predict

Sugi Predict / Compounds / SCHEMBL2325955

SCHEMBL2325955

SCHEMBL2325955

CC(C)(C)[Si](C)(C)Oc1ccccc1CBr

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 2/20 0.36
▸ IDO1 P14902 2/20 0.35
▸ HTT P42858 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ PREP P48147 2/20 0.33
▸ TAAR1 Q96RJ0 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ CA12 O43570 4/20 0.31
▸ CA1 P00915 4/20 0.31
▸ CA9 Q16790 4/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ ELANE P08246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7240943 1.00 RIPK1 (0.36) RIPK1IDO1HTTDRD2PREP
SCHEMBL30556213 0.86 CA1 (0.38) RIPK1DRD2PREPCA12CA1
SCHEMBL19812300 0.86 TAAR1 (0.37) RIPK1IDO1HTTDRD2PREP
SCHEMBL15283292 0.85 RIPK1 (0.36) RIPK1IDO1HTTDRD2PREP
SCHEMBL9853837 0.85 L3MBTL1 (0.44) RIPK1IDO1DRD2PREP
SCHEMBL6943654 0.84 CYP4F2 (0.36) RIPK1IDO1HTTDRD2BACE1
SCHEMBL30039264 0.84 CYP4F2 (0.36) RIPK1IDO1HTTDRD2BACE1
SCHEMBL3149357 0.84 RIPK1 (0.35) RIPK1IDO1HTTPREPTAAR1
SCHEMBL10582602 0.82 IDO1 (0.34) RIPK1IDO1TAAR1CA12CA1
SCHEMBL8700617 0.82 ADRA2A (0.41) RIPK1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452955-A1 METAL COMPLEXES, AND DISHWASHING PRODUCTS CONTAINING SAME Henkel AG & Co. KGaA (DE) 2024-10-30 — — EP disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 — — US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 — — US disclosed
WO-2023117380-A1 METAL COMPLEXES, AND DISHWASHING PRODUCTS CONTAINING SAME HENKEL AG & CO. KGAA (DE) 2023-06-29 — — WO disclosed
WO-2023277630-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR 주식회사 티움바이오 2023-01-05 — — WO disclosed
WO-2023277630-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR 주식회사 티움바이오 2023-01-05 — — WO disclosed
CN-111372936-B Mcl-1 selective inhibitors, their preparation and use 北京赛林泰医药技术有限公司 2022-12-02 — — CN disclosed
CN-111372936-A Mcl-1 selective inhibitors, their preparation and use 北京赛林泰医药技术有限公司 2020-07-03 — — CN disclosed
WO-2019101144-A1 SELECTIVE MCL-1 INHIBITOR AND PREPARATION AND USE THEREOF 北京赛林泰医药技术有限公司 2019-05-31 — — WO disclosed
US-9643947-B2 7-membered fused heterocycles and methods of their synthesis NORTHWESTERN UNIVERSITY (US) 2017-05-09 — — US disclosed
WO-2005066144-A1 MORPHOLINE DERIVATIVES AS NOREPINEPHRINE REUPTAKE INHIBITORS ELI LILLY AND COMPANY (US) 2005-07-21 — — WO disclosed
EP-1515972-A1 AMIDE SUBSTITUTED XANTHINE DERIVATIVES WITH GLUCONEOGENESIS MODULATING ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-03-23 — — EP disclosed
US-20040014766-A1 Amide substituted xanthine derivatives HOFFMANN-LA ROCHE INC. 2004-01-22 — — US disclosed
WO-2003106459-A1 AMIDE SUBSTITUTED XANTHINE DERIVATIVES WITH GLUCONEOGENESIS MODULATING ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2003-12-24 — — WO disclosed
US-20020161006-A1 1,4-dihydropyridine compounds as bradykinin antagonists KAWAMURA MITSUHIRO (US) 2002-10-31 — — US disclosed
EP-0853618-A4 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2000-03-15 — — EP disclosed
EP-0853618-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-07-22 — — EP disclosed
US-5677336-A ADMINISTERING TO MAMMALS TO MODULATE PROCESSES MEDIATED BY ANDROGEN RECEPTOR LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-10-14 — — US disclosed
WO-1996040679-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-12-19 — — WO disclosed
WO-1995011215-A1 NON-STEROID ANDROGEN RECEPTOR ANTAGONISTS LIGAND PHARMACEUTICALS INCORPORATED (US) 1995-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014766-A1 Amide substituted xanthine derivatives GYS2, GLS2, PYGL RIPK1 3026/4885IDO1 1556/4885HTT 4698/4885
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT RIPK1 4465/4885IDO1 525/4885HTT 1393/4885
US-20020161006-A1 1,4-dihydropyridine compounds as bradykinin antagonists BDKRB1, BDKRB2, HRH4 RIPK1 3043/4885IDO1 292/4885HTT 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.